Sexual health

The Mycoplasma Genitalium Testing Window

Save

People searching for an M. genitalium window are usually looking for a magic number of days, the way HIV or chlamydia has one. The honest answer is different: this is a NAAT that reads the organism directly, and it is not a routine post-exposure screen. Here is what that means for timing, when testing is actually recommended, and why a resistance test can follow a positive.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

How long after exposure should you test for mycoplasma genitalium?

M. genitalium is detected by a NAAT, which looks for the bacteria's genetic material directly rather than for antibodies your body makes over time. That means there is no seroconversion wait built into the test the way there is with an antibody test. But there is no established, guideline-defined post-exposure window number for it either, because M. genitalium is not recommended as a routine or first-line screen 1. It is tested mainly when symptoms persist, so the practical timing question is less "how many days" and more "are there symptoms that call for the test." there is no standard number of days for an M. genitalium test, because it is not a routine post-exposure screen.

Why there's no standard window number

Chlamydia, gonorrhea, and HIV each have testing windows because they are screened routinely, so guidelines specify when the test becomes reliable. M. genitalium is handled differently. Testing for it is not recommended as part of an initial cervicitis or urethritis workup, and is generally reserved for symptoms that persist after treatment 1. Because there is no routine screening protocol, there is no standard post-exposure window to publish — the test is triggered by a clinical picture, not by a calendar. That is a real answer, not a gap: the framing of "days since exposure" applies to screening programs M. genitalium is not part of.

A NAAT detects the organism, not antibodies

A NAAT — nucleic acid amplification test — copies and detects a pathogen's genetic material, so it can find an organism directly. This is why the timing logic differs from an antibody test. With antibodies, you wait for the immune system to respond; with a NAAT, the limiting factor is simply whether enough organism is present at the sampled site to detect. NAATs detect infection early for this reason — an HIV nucleic-acid test, for instance, can pick up the virus roughly 10 to 33 days after exposure, well before antibody tests 2. Self-collected samples work well for NAAT-based STI testing, reaching high sensitivity and specificity against clinician-collected ones, so a swab you take yourself is a valid specimen 3. The practical implication is that testing extremely soon after an exposure — within a day or two — risks catching too little organism to register, which is one more reason the test is timed to symptoms rather than to the exposure itself.

What sample does the test use?

An M. genitalium NAAT runs on a urine sample or a swab, chosen to fit the site and the person: a first-catch urine or a urethral swab for men, and a vaginal, cervical, or urine sample for women. Because it is a NAAT, the specimen only has to contain enough of the organism to detect — there is no antibody level to wait on. Self-collected swabs perform well for this kind of testing, reaching high sensitivity and specificity against clinician-collected ones, so collecting your own sample is a valid option where the test is offered 3. Which specimen is best is a question for the ordering clinician, because availability and validated sample types vary by lab, and M. genitalium testing is not stocked everywhere the way chlamydia and gonorrhea testing is.

Why a resistance test can follow a positive

A positive M. genitalium result is often not the end of the workup. The infection is frequently resistant to the antibiotics that would otherwise be used, so the recommended approach differs depending on whether it is macrolide-sensitive or macrolide-resistant 1. Where resistance testing is available, it follows a positive result to guide which treatment fits — a resistance-guided step rather than a one-size regimen. This is why a positive M. genitalium test can lead to a second lab step before any treatment decision, and why the answer to "what happens next" is rarely a single prescription. It sits within a larger STI trend: drug-resistant gonorrhea is now considered an urgent public-health threat, having outrun nearly every antibiotic once used against it 4. The treatment details themselves belong with a clinician, and the how-it-is-treated story is covered separately, but the reason resistance testing exists is worth understanding — treating blindly can drive more resistance.

How this compares to other test windows

Because M. genitalium sits outside routine screening, the clearer window questions are the ones asked about the infections that are screened. Each has its own NAAT timeline: the chlamydia test window and the gonorrhea test window run on the organism being present at the site, the trich test window has its own timing, and blood-borne infections differ again — the hepatitis b window and the hiv testing window depend on the specific test type used. Antibody-based tests carry a true waiting period while the immune system responds; NAAT-based tests do not, because they read the organism itself 2. The point that carries across all of them is that a NAAT looks for the organism directly, so timing is about the organism being detectable, not about waiting for an antibody response. For M. genitalium specifically, that means the honest guide to timing is your symptoms and your clinician's judgment, not a fixed count of days on a calendar.

Common questions

No. Unlike chlamydia, gonorrhea, or HIV, M. genitalium has no established post-exposure window number, because it is not tested as a routine screen. It is a NAAT that detects the organism directly, and it is generally ordered when symptoms persist after treatment rather than on a fixed schedule after an exposure.

No. It is a NAAT, which detects the bacteria's genetic material directly. That means there is no seroconversion delay to wait out, unlike an antibody test. The limiting factor is whether enough of the organism is present at the sampled site to be detected, not how long the immune system has had to respond.

Usually when symptoms persist — urethritis in men or cervicitis in women that does not clear after standard treatment. It is not part of an initial or routine workup. In that persistent-symptom setting the test can explain a stubborn infection, which is why it tends to be ordered after first-line treatment rather than at a first visit.

A positive is often followed by resistance testing where it is available, because M. genitalium is frequently resistant to the usual antibiotics. The recommended approach differs for macrolide-sensitive versus macrolide-resistant infection, so the resistance result helps guide treatment. The specific regimen is decided with a clinician, not from a fixed protocol.

Self-collected samples perform well for NAAT-based STI testing, reaching high sensitivity and specificity compared with clinician-collected ones, so a swab you take yourself is a valid specimen. Availability of M. genitalium testing specifically varies by clinic and lab, so it is worth confirming the test is offered before relying on a given kit.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When persistent symptoms need a closer look

  • —Urethral or vaginal symptoms that do not clear after a course of treatment
  • —Lower-abdominal or pelvic pain with fever, which can signal pelvic inflammatory disease
  • —Pain or bleeding with sex, or unusual discharge that keeps returning
  • —A partner with a confirmed infection while your own symptoms persist

Pelvic pain with a fever, or pain severe enough to stop you functioning, needs same-day evaluation at urgent care or the emergency department — call 911 if it is sudden and disabling.

This article is health education, not medical advice. It cannot decide whether you need testing or treatment; a licensed clinician determines when an M. genitalium test is appropriate and how to act on the result.

References

  1. 1.Centers for Disease Control and Prevention (2021). Mycoplasma genitalium - STI Treatment Guidelines. CDC STI Treatment Guidelines, 2021. linkM. genitalium testing is not recommended for an initial cervicitis or urethritis workup and is generally reserved for symptoms that persist after empiric treatment; the recommended approach differs for macrolide-sensitive versus macrolide-resistant infection.
  2. 2.Centers for Disease Control and Prevention (2024). Clinical Testing Guidance for HIV. CDC HIV Nexus. linkNAATs detect infection early by finding nucleic acid directly — an HIV nucleic-acid test can detect the virus roughly 10-33 days after exposure, ahead of antibody tests — illustrating why NAAT timing depends on the organism being present rather than on an antibody response.
  3. 3.Lunny C, Taylor D, Hoang L, et al. (2015). Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systematic Review and Meta-Analysis. PLoS One 10(7):e0132776. doi:10.1371/journal.pone.0132776 ✓Self-collected swabs for NAAT-based STI testing reach high sensitivity (~92%) and specificity (~98%) against clinician-collected samples, supporting self-collection as a valid specimen option.
  4. 4.Centers for Disease Control and Prevention (2024). Drug-Resistant Gonorrhea. CDC (cdc.gov/gonorrhea). linkAntibiotic resistance is a growing STI problem — drug-resistant gonorrhea is designated an urgent public-health threat, having developed resistance to nearly every antibiotic used against it — providing context for why resistance-guided treatment matters.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library